Pharmacology & Pharmacy

Volume 2, Issue 3 (July 2011)

ISSN Print: 2157-9423   ISSN Online: 2157-9431

Google-based Impact Factor: 0.70  Citations  h5-index & Ranking

Characterization of Bucolome N-Glucuronide Formation: Tissue Specificity and Identification of Rat UDP-Glucuronosyltransferase Isoform (s)

HTML  Download Download as PDF (Size: 350KB)  PP. 151-158  
DOI: 10.4236/pp.2011.23021    4,315 Downloads   8,411 Views  Citations

ABSTRACT

Bucolome N-glucuronide (BCP-NG, main metabolite of bucolome (BCP) is the first N-glucuronide of barbituric acid derivatives isolated from rat bile. The objective of this study was to identify the main tissue producing BCP-NG and the molecular species of BCP-NG-producing UGT. Four target tissues were investigated: the liver, small and large intestines, and kidney. To identify the UGT molecular species responsible for BCP-NG formation, yeast microsomes expressing each rat UGT isoform were prepared. BCP-NG formation was detected in all microsomal fractions of the 4 tissues. The liver microsomal BCP-NG-producing activity was the highest, followed by that in the small intestinal microsomes, showing about 41% of the liver microsomal activity level. BCP-NG-producing activity (min-1) was determined in yeast microsomal fractions expressing rat UGT isoforms, and the activity was detected in UGT1A1 (0.059), UGT1A2 (0.318), UGT1A3 (0.001), UGT1A7 (0.003), UGT2B1 (0.004), UGT2B3 (0.091), and UGT2B6 (0.031), showing particularly high levels for UGT1A1 and UGT1A2 among the UGT1A isoforms. It was clarified that UGT1A1, widely distributed in rat tissues, is the molecular species responsible for BCP-NG formation.

Share and Cite:

H. Kanoh, M. Tada, S. Ikushiro and K. Mohri, "Characterization of Bucolome N-Glucuronide Formation: Tissue Specificity and Identification of Rat UDP-Glucuronosyltransferase Isoform (s)," Pharmacology & Pharmacy, Vol. 2 No. 3, 2011, pp. 151-158. doi: 10.4236/pp.2011.23021.

Cited by

[1] 薬物代謝酵素群発現酵母株を用いた医薬品及び食品成分代謝物調製技術の開発
2021
[2] Disposition of mianserin and cyclizine in UGT2B10-overexpressing HEK293 cells: Identification of UGT2B10 as a novel N-glucosidation enzyme and BCRP as an N …
2018
[3] Disposition of Mianserin and Cyclizine in UGT2B10-Overexpressing Human Embryonic Kidney 293 Cells: Identification of UGT2B10 as a Novel N-Glucosidation …
2018
[4] Disposition of mianserin and cyclizine in UGT2B10-overexpressing HEK293 cells: Identification of UGT2B10 as a novel N-glucosidation enzyme and BCRP as …
2018
[5] Disposition of mianserin and cyclizine in UGT2B10-overexpressing human embryonic kidney 293 cells: identification of UGT2B10 as a novel N-glucosidation enzyme …
2018
[6] Biosynthesis of Drug Glucuronide Metabolites in Budding Yeast Saccharomyces cerevisiae
Molecular pharmaceutics, 2016
[7] Biosynthesis of Drug Glucuronide Metabolites in the Budding Yeast Saccharomyces cerevisiae
Molecular Pharmaceutics, 2016
[8] Bucolome N-Glucuronide Formation: Species Differences and Identification of Human UDP-Glucuronosyltransferase Isoforms
Pharmacology & Pharmacy, 2011
[9] Disposition of mianserin and cyclizine in UGT2B10-overexpressing HEK293 cells

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.